Skip to main content
Caplight Logo









Indigo Diabetes N.V.

Indigo Diabetes N.V.

Private
BelgiumHealthcare & Life Scienceshttps://indigomed.com/

Last Round

Accelerator

Jun 5, 2025

Total Funding Raised

$55.52M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Indigo Diabetes N.V. is a medical technology company that develops implantable continuous multi-metabolite monitoring (CMM) sensors for the management of chronic diseases such as diabetes.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Clinical Trials

Business Model

B2B2C

Customer Profile

Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

continuous multi-metabolite monitoringCMMimplantable sensorsilicon photonicsdiabetes managementcgmneedle-free monitoringmedtechdigital healthhealth iotsmart implantspectroscopymetabolite sensingchronic disease managementbio-sensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Indigo Diabetes N.V. Comparables

Compare Indigo Diabetes N.V. with similar companies based on industry and business-model similarity.

Indigo Diabetes N.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
GlySens Incorporated
81%
GlucoModicum
80%
Laxmi Therapeutic Devices
79%

Indigo Diabetes N.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 5, 2025
GrantSep 7, 2021
Series BJul 27, 2020
GrantJul 1, 2018
Series ADec 19, 2016

Key People

Founding team and executive leadership

Danaë Delbeke

CEO, Founder

Founding Team

Emmet Lydon

Chief Operating Officer at Indigo Diabetes

Executive Team

Indigo Diabetes N.V. Investors

Notable investors and investment history

Indigo Diabetes N.V. investors
InvestorRounds
Ackermans & van HaarenSeries B
Fund+Series B
MedTech InnovatorAccelerator
imec.xpandSeries B
PMVSeries B, Series A
Qbic IISeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 21, 2026

    Monthly visitors grew 351% MoM, reaching 3.5K.

  • Jan 21, 2026

    Monthly visitors increased 264% MoM, reaching 2.4K.

Indigo Diabetes N.V. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Indigo Diabetes N.V. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Indigo Diabetes N.V.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBelgium
Employee Range33
Year Founded2016
Last FundingJun 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?